BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8913244)

  • 21. Evaluation of the PAPNET system in a general pathology service.
    Baird PJ
    Med J Aust; 1997 Sep; 167(5):285-6. PubMed ID: 9315021
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of PAPNET-assisted cervical rescreening.
    Doornewaard H; Woudt JM; Strubbe P; van de Seijp H; van den Tweel JG
    Cytopathology; 1997 Oct; 8(5):313-21. PubMed ID: 9313983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significant reduction in the rate of false-negative cervical smears with neural network-based technology (PAPNET Testing System).
    Koss LG; Sherman ME; Cohen MB; Anes AR; Darragh TM; Lemos LB; McClellan BJ; Rosenthal DL; Keyhani-Rofagha S; Schreiber K; Valente PT
    Hum Pathol; 1997 Oct; 28(10):1196-203. PubMed ID: 9343327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atypical squamous cells of undetermined significance: a comparative review of original and automated rescreen diagnosis of cervicovaginal smears with long term follow-up.
    Stastny JF; Remmers RE; London WB; Pedigo MA; Cahill LA; Ryan M; Frable WJ
    Cancer; 1997 Dec; 81(6):348-53. PubMed ID: 9438460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of false-negative ThinPrep cervical smears in women with high-grade squamous intraepithelial lesions.
    Leung KM; Lam KK; Tse PY; Yeoh GP; Chan KW
    Hong Kong Med J; 2008 Aug; 14(4):292-5. PubMed ID: 18685162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computer-assisted rescreening of clinically important false negative cervical smears using the PAPNET Testing System.
    Rosenthal DL; Acosta D; Peters RK
    Acta Cytol; 1996; 40(1):120-6. PubMed ID: 8604564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PAPNET computer-aided rescreening for detection of benign and malignant glandular elements in cervicovaginal smears: a review of 61 cases.
    Sturgis CD; Isoe C; McNeal NE; Yu GH; DeFrias DV
    Diagn Cytopathol; 1998 Apr; 18(4):307-11. PubMed ID: 9557269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences between false-negative and true-positive Papanicolaou smears on Papnet-assisted review.
    Mitchell H; Medley G
    Diagn Cytopathol; 1998 Aug; 19(2):138-40. PubMed ID: 9702494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rescreening in gynecologic cytology. Rescreening of 8096 previous cases for current low-grade and indeterminate-grade squamous intraepithelial lesion diagnoses--a College of American Pathologists Q-Probes study of 323 laboratories.
    Jones BA
    Arch Pathol Lab Med; 1996 Jun; 120(6):519-22. PubMed ID: 8651851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [An interlaboratory study of the use of PapNet in the quality control of cervico-vaginal cytology].
    Cosentino A; Ghidoni D; Salemi M; Folicaldi S; Amadori A; Zani J; Grasso G; Bondi A
    Pathologica; 1999 Apr; 91(2):101-6. PubMed ID: 10484869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristic findings of cervical Papanicolaou tests from transgender patients on androgen therapy: Challenges in detecting dysplasia.
    Adkins BD; Barlow AB; Jack A; Schultenover SJ; Desouki MM; Coogan AC; Weiss VL
    Cytopathology; 2018 Jun; 29(3):281-287. PubMed ID: 29488269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality control of cervical cytology in high-risk women. PAPNET system compared with manual rescreening.
    Bergeron C; Masseroli M; Ghezi A; Lemarie A; Mango L; Koss LG
    Acta Cytol; 2000; 44(2):151-7. PubMed ID: 10740599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance of a semiautomated Papanicolaou smear screening system: results of a population-based study conducted in Guanacaste, Costa Rica.
    Sherman ME; Schiffman M; Herrero R; Kelly D; Bratti C; Mango LJ; Alfaro M; Hutchinson ML; Mena F; Hildesheim A; Morales J; Greenberg MD; Balmaceda I; Lorincz AT
    Cancer; 1998 Oct; 84(5):273-80. PubMed ID: 9801201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of unsatisfactory conventional pap smears owing to inadequate squamous cellularity defined by the Bethesda 2001 criterion.
    Adams AL; Gidley J; Roberson J; Wang W; Eltoum I; Chhieng DC
    Am J Clin Pathol; 2005 May; 123(5):738-43. PubMed ID: 15981813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liquid-based cytology and conventional cervical smears: a comparison study in an Asian screening population.
    Cheung AN; Szeto EF; Leung BS; Khoo US; Ng AW
    Cancer; 2003 Dec; 99(6):331-5. PubMed ID: 14681939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Follow up of atypical squamous cell Pap smears in Iraqi women.
    Pity IS; Shamdeen MY; Wais SA
    Asian Pac J Cancer Prev; 2012; 13(7):3455-60. PubMed ID: 22994777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Abnormal Pap Smear with Occult Cervical Stromal Invasion in Patients with Endometrial Cancer.
    Khumthong K; Aue-Aungkul A; Kleebkaow P; Chumworathayi B; Temtanakitpaisan A; Nhokaew W
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2847-2850. PubMed ID: 31554386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pattern of abnormal Pap smears in developing countries: a report from a large referral hospital in Saudi Arabia using the revised 2001 Bethesda System.
    Abdullah LS
    Ann Saudi Med; 2007; 27(4):268-72. PubMed ID: 17684431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost analysis of PAPNET-assisted vs. conventional Pap smear evaluation in primary screening of cervical smears.
    Meerding WJ; Doornewaard H; van Ballegooijen M; Bos A; van der Graaf Y; van den Tweel JG; van der Schouw YT; Habbema JD
    Acta Cytol; 2001; 45(1):28-35. PubMed ID: 11213501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A feasibility study of the AutoPap system location-guided screening.
    Lee JS; Kuan L; Oh S; Patten FW; Wilbur DC
    Acta Cytol; 1998; 42(1):221-6. PubMed ID: 9479344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.